Helixmith Co., Ltd (KOSDAQ:084990)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,540.00
+490.00 (8.10%)
Aug 28, 2025, 3:30 PM KST
8.10%
Market Cap301.15B
Revenue (ttm)5.09B
Net Income (ttm)-11.64B
Shares Out46.05M
EPS (ttm)-251.71
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,370,363
Average Volume698,723
Open6,090.00
Previous Close6,050.00
Day's Range6,050.00 - 6,690.00
52-Week Range2,115.00 - 6,590.00
Beta1.53
RSI89.64
Earnings DateAug 14, 2025

About Helixmith

Helixmith Co., Ltd develops biologic and natural nutraceutical products. The company offers LAYLA Tab for osteoarthritis; Allex and Allex i for hypersensitivity improvement; and Mnemosyne for memory improvement. Its lead gene therapy product is Engensis (VM202), which is in a phase III clinical trial for diabetic peripheral neuropathy and diabetic foot ulcer; a phase II clinical trial for amyotrophic lateral sclerosis (ALS) and claudication; and a phase I clinical trial for charcot-marie-tooth disease and coronary artery disease. The company al... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1996
Employees 33
Stock Exchange KOSDAQ
Ticker Symbol 084990
Full Company Profile

Financial Performance

In 2024, Helixmith's revenue was 4.97 billion, an increase of 18.38% compared to the previous year's 4.20 billion. Losses were -15.47 billion, -75.86% less than in 2023.

Financial Statements

News

P/E Ratio Insights for Vipshop Holdings

In the current session, Vipshop Holdings Inc. (NYSE: VIPS) is trading at $15.27, after a 0.52% drop. Over the past month, the stock decreased by 9.59% , and in the past year, by 10.96% . With perform...

5 months ago - Benzinga

Price Over Earnings Overview: Vipshop Holdings

In the current market session, Vipshop Holdings Inc. (NYSE: VIPS) share price is at $13.85, after a 4.09% decrease. Over the past month, the stock increased by 13.78% , but over the past year, it act...

1 year ago - Benzinga